Darren J. Carroll

DARREN J. CARROLL is chief executive officer of InnoCentive, Inc. As the
director of new venture development for e.Lilly, the venture capital arm
of Eli Lilly and Company, Carroll led the team that created InnoCentive
in only 103 days. InnoCentive, the first e-business venture created by
e.Lilly, is one of several open-source R&D initiatives on which Carroll
has worked. Prior to assuming his duties in e.Lilly, Carroll had a
number of positions at Eli Lilly and Company, a leading innovation-
driven pharmaceutical corporation. As the U.S. attorney for Prozac, the
all-time top-selling antidepressant, Carroll was responsible for
advising the company on all legal issues pertaining to the marketing and
related clinical development of antidepressants in the Lilly pipeline.
Before taking on responsibilities for Prozac, he was Lilly’s first
technology attorney, responsible for legal issues pertaining to the
company’s substantial portfolio of technologies, including its former
technology-based subsidiaries, e.g., IMS Corp., which is now part of
WebMD. His legal experience includes highly complex licensing and
outsourcing transactions, mergers and acquisitions, and commercial
matters related to technology companies. Carroll has also served as an
executive with RealMed, an Internet company based in Indianapolis, which
created the first U.S. real-time health claims adjudication system. His
responsibilities at RealMed included corporate development, new product
development, and sales and marketing. Earlier in his career, he
practiced law with a large private law firm in New York and negotiated
technology transactions for General Electric Company. Carroll’s
education includes a J.D. degree from the Syracuse University College of
Law. At Syracuse, he was a member of the Law Review and Order of the
Coif. He also holds a bachelor’s from Syracuse University Kappa) and a
masters of public administration degree from the Maxwell School of
Syracuse. He is the recipient of numerous fellowships, including the
prestigious LES and Lehman fellowships. He has published articles on
topics ranging from software licensing to human resource matters.